stallimycin has been researched along with Osteosarcoma in 1 studies
Osteosarcoma: A sarcoma originating in bone-forming cells, affecting the ends of long bones. It is the most common and most malignant of sarcomas of the bones, and occurs chiefly among 10- to 25-year-old youths. (From Stedman, 25th ed)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zaffaroni, N | 1 |
| Lualdi, S | 1 |
| Villa, R | 1 |
| Bellarosa, D | 1 |
| Cermele, C | 1 |
| Felicetti, P | 1 |
| Rossi, C | 1 |
| Orlandi, L | 1 |
| Daidone, MG | 1 |
1 other study available for stallimycin and Osteosarcoma
| Article | Year |
|---|---|
Inhibition of telomerase activity by a distamycin derivative: effects on cell proliferation and induction of apoptosis in human cancer cells.
Topics: Antineoplastic Agents; Antiviral Agents; Apoptosis; Carcinoma, Non-Small-Cell Lung; Cell Division; D | 2002 |